Original articleA Prospective Randomized Trial of Intravitreal Bevacizumab Versus Ranibizumab for the Management of Diabetic Macular Edema
Cited by (0)
Antonio Brunno Nepomuceno received his medical degree from the Federal University of Ceará, Fortaleza, Brazil. In 2011, he completed his ophthalmology residency and started working as a retinal fellowship trainning at the School of Medicine of Ribeirao Preto, University of São Paulo, Ribeirão Preto, Brazil. His primary research interests pertain to diabetic retinopathy, macular edema and anti-VEGF agents.
Rodrigo Jorge is an Associate Professor and coordinates the Postgraduate program in the Ophthalmology Department and in the Retina and Vitreous Division in Clinics Hospital, School of Medicine of Ribeirão Preto, University of São Paulo. He has taught and published in the field of vitreoretinal diseases, with over 80 publications. Since 2006, his research has focused on anti-VEGF therapy studies and his collaborative study group has published the most cited prospective studies of age-related macular degeneration and diabetic retinopathy conceived and conducted in Brazil.